In summary, our data demonstrated that the PNKP inhibitor, A83B4C63 loaded into mPEO-b-PBCL nanocarriers leads to additional radio-sensitizing effects in a CRC model, as analyzed both in vitro and in vivo. This evidence concerns the gene PNKP and colorectal carcinoma.